Raphael Lutz

618 total citations
11 papers, 51 citations indexed

About

Raphael Lutz is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Raphael Lutz has authored 11 papers receiving a total of 51 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Raphael Lutz's work include Multiple Myeloma Research and Treatments (7 papers), Protein Degradation and Inhibitors (3 papers) and Mesenchymal stem cell research (2 papers). Raphael Lutz is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Protein Degradation and Inhibitors (3 papers) and Mesenchymal stem cell research (2 papers). Raphael Lutz collaborates with scholars based in Germany and United States. Raphael Lutz's co-authors include Hannah J. Uckelmann, Anne Marie Asemissen, Marieke Essers, Hartmut Goldschmidt, Britta Besemer, Christoph Mann, Carsten Bokemeyer, Axel Benner, Diana Tichy and Katja Weisel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancers.

In The Last Decade

Raphael Lutz

9 papers receiving 51 citations

Peers

Raphael Lutz

HEMAT

ONCOL

IMMUN

GENET

Titouan Cazaubiel France

Mariella Genuardi Italy

Nitin Patel United States

Selina Qiuying Liu United States

Matthew R. Hart United States

Camille Montersino France

D. H. Vesole United States

Minna Suvela Finland

Meral Beksac Türkiye

Cody Coblentz United States

Titouan Cazaubiel France

Raphael Lutz

51 ×1.3

HEMAT

41 ×1.3

33 ×1.5

ONCOL

6 ×0.5

IMMUN

8 ×1.3

GENET

Citations per year, relative to Raphael Lutz Raphael Lutz (= 1×) peers Titouan Cazaubiel

Countries citing papers authored by Raphael Lutz

Since Specialization

Citations

This map shows the geographic impact of Raphael Lutz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Lutz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Lutz more than expected).

Fields of papers citing papers by Raphael Lutz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphael Lutz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Lutz. The network helps show where Raphael Lutz may publish in the future.

Co-authorship network of co-authors of Raphael Lutz

This figure shows the co-authorship network connecting the top 25 collaborators of Raphael Lutz. A scholar is included among the top collaborators of Raphael Lutz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphael Lutz. Raphael Lutz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Lutz, Raphael, Florian Grünschläger, Andrea Kuck, et al.. (2022). A complex proinflammatory cascade mediates the activation of HSCs upon LPS exposure in vivo. Blood Advances. 6(11). 3513–3528. 15 indexed citations

John, Lukas, Alexandra M. Poos, Stephan M. Tirier, et al.. (2021). The Spatial Heterogeneity in Newly Diagnosed Multiple Myeloma Patients - from Sub-Clonal Architecture to the Immune Microenvironment. Blood. 138(Supplement 1). 729–729. 3 indexed citations

Lutz, Raphael, Mirco Friedrich, Marc S. Raab, Niels Weinhold, & Hartmut Goldschmidt. (2021). Therapeutic Advances Propelled by Deciphering Tumor Biology and Immunology—Highlights of the 8th Heidelberg Myeloma Workshop. Cancers. 13(16). 4135–4135.

Lutz, Raphael, Charles D. Imbusch, Tobias Boch, et al.. (2020). The Bone Marrow Microenvironment of Multiple Myeloma Long-Term Survivors at Single Cell Resolution. Blood. 136(Supplement 1). 32–33. 2 indexed citations

Weisel, Katja, Anne Marie Asemissen, Britta Besemer, et al.. (2020). Depth of response to isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: Interim analysis of the GMMG-CONCEPT trial.. Journal of Clinical Oncology. 38(15_suppl). 8508–8508. 15 indexed citations

Lutz, Raphael, et al.. (2019). Meeting report of the 7th Heidelberg Myeloma Workshop: today and tomorrow. Journal of Cancer Research and Clinical Oncology. 145(10). 2445–2455.

Weisel, Katja, Anne Marie Asemissen, Aneta Schieferdecker, et al.. (2019). Isatuximab, Carfilzomib, Lenalidomide and Dexamethasone (I-KRd) in front-line treatment of high-risk Multiple Myeloma: Results of the Safety Run-In cohort in the phase II, multicenter GMMG-CONCEPT trial. Clinical Lymphoma Myeloma & Leukemia. 19(10). e17–e17. 10 indexed citations

Lutz, Raphael, Katharina Kriegsmann, Carsten Müller‐Tidow, et al.. (2018). Characterization of Patients with Multiple Myeloma in Long- Term Remission. Blood. 132(Supplement 1). 4508–4508. 2 indexed citations

Essers, Marieke, et al.. (2011). Stress-Induced Activation of Dormant Hematopoietic Stem Cells In Vivo,. Blood. 118(21). 3390–3390. 2 indexed citations

10.

Essers, Marieke, Raphael Lutz, Andrea Kern, Stephan Wurzer, & Andreas Trumpp. (2010). Activation of Dormant Hematopoietic Stem Cells In Vivo by the Endotoxin LPS.. Blood. 116(21). 1613–1613. 1 indexed citations

11.

Wrobel, Karl‐Heinz, Richard Kujat, & Raphael Lutz. (2009). Expression of the proliferation-associated Ki-67 antigen in bovine testicular tubular cells during the seminiferous epithelial cycle, demonstrated with the MIB-1 antibody. Andrologia. 25(5). 301–305. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact